Arab Journal of Gastroenterology
Volume 12, Issue 3 , Pages 113-118 , September 2011

Radiofrequency ablation combined with percutaneous ethanol injection in patients with hepatocellular carcinoma

  • Mohamed Azab

      Affiliations

    • Department of Tropical Medicine, Al-Azhar University, Cairo, Egypt
    • ,
  • Samy Zaki

      Affiliations

    • Department of Tropical Medicine, Al-Azhar University, Damietta, Egypt
    • ,
  • Anwar G. El-Shetey

      Affiliations

    • Department of Tropical Medicine, Al-Azhar University, Cairo, Egypt
    • ,
  • Mohamed F. Abdel-Moty

      Affiliations

    • Department of Radiodiagnosis, Al-Azhar University, Cairo, Egypt
    • ,
  • Nabil M.G. Alnoomani

      Affiliations

    • Department of Tropical Medicine, Al-Azhar University, Damietta, Egypt
    • Corresponding Author InformationCorresponding author. Address: Tropical Medicine, Hepatology, and Gastroenterology Department, Al-Azhar University, Damietta, Egypt.
    • ,
  • Ahmad A. Gomaa

      Affiliations

    • Department of Tropical Medicine, Al-Azhar University, Damietta, Egypt
    • ,
  • Sabry Abdel-Fatah

      Affiliations

    • Department of Tropical Medicine, Al-Azhar University, Cairo, Egypt
    • ,
  • Sayed Mohiy

      Affiliations

    • Department of Tropical Medicine, Al-Azhar University, Cairo, Egypt
    • ,
  • Faried Atia

      Affiliations

    • Department of Tropical Medicine, Al-Azhar University, Damietta, Egypt

Received 16 December 2010 ,Accepted 13 July 2011.

References 

  1. Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol. 2005;40(3):225–235
  2. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55(2):74–108.
  3. El Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340(10):745–750
  4. Bosch FX, Ribes J, Díaz M, et al. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127(Suppl.):S5–S16
  5. Llovet JM, Bustamante J, Castells A, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999;29(1):62–67
  6. Arguedas MR, Chen VK, Eloubeidi MA, et al. Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis. Am J Gastroenterol. 2003;98(3):679–690
  7. Llovet JM, Beaugrand M. Hepatocellular carcinoma: present status and future prospects. J Hepatol. 2003;38(Suppl 1):S136–S149
  8. Kurokohchi K, Watanabe S, Masaki T, et al. Comparison between combination therapy of percutaneous ethanol injection and radiofrequency ablation and radiofrequency ablation alone for patients with hepatocellular carcinoma. World J Gastroenterol. 2005;11(10):1426–1432
  9. Bolondi L, Sofia S, Siringo S, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut. 2001;48(2):251–259
  10. Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J Hepatol. 2003;39(6):1076–1084
  11. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208–1236
  12. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35(3):519–524
  13. Hertl M, Cosimi AB. Liver transplantation for malignancy. Oncologist. 2005;10(4):269–281
  14. Sutherland LM, Williams JA, Padbury RT, et al. Radiofrequency ablation of liver tumors: a systematic review. Arch Surg. 2006;141(2):181–190
  15. Lu DS, Yu NC, Raman SS, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology. 2005;41(5):1130–1137
  16. Salmi A, Turrini R, Lanzani G, et al. Efficacy of radiofrequency ablation of hepatocellular carcinoma associated with chronic liver disease without cirrhosis. Int J Med Sci. 2008;5(6):327–332
  17. Wong SN, Lin CJ, Lin CC, et al. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations. Am J Roentgenol. 2008;190(3):W187–W195
  18. Zytoon AA, Ishii H, Murakami K, et al. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome. Jpn J Clin Oncol. 2007;37(9):658–672
  19. Dromain C, de Baere T, Elias D, et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology. 2002;223(1):255–262
  20. Zhang YJ, Liang HH, Chen MS, et al. Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trial. Radiology. 2007;244(2):599–607
  21. Francica G, Marone G. Ultrasound-guided percutaneous treatment of hepatocellular carcinoma by radiofrequency hyperthermia with a ‘cooled-tip needle’. A preliminary clinical experience. Eur J Ultrasound. 1999;9(2):145–153
  22. Kurokohchi K, Watanabe S, Masaki T, et al. Combined use of percutaneous ethanol injection and radiofrequency ablation for the effective treatment of hepatocelluar carcinoma. Int J Oncol. 2002;21(4):841–846
  23. Kurokohchi K, Watanabe S, Masaki T, et al. Combination therapy of percutaneous ethanol injection and radiofrequency ablation against hepatocellular carcinomas difficult to treat. Int J Oncol. 2002;21(3):611–615
  24. Colombo M. Risk groups and preventive strategies. In: Berr F, Bruix J, Wands J, et al., editors. Malignant liver tumors: basic concepts and clinical management. Dordvecht, The Netherlands: Kluwer Academic Publishers, BV and Falk Foundation; 2003. p. 67–74.
  25. Lehman EM, Wilson ML. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: a systematic review and meta-analysis. Int J Cancer. 2009;124(3):690–697
  26. Esmat G. Hepatocellular carcinoma: the magnitude of the problem in Egypt. In: The fifth international congress of the egyptian society of hepatology, gastroenterology and infectious diseases. Nov 5–11, Egypt, 2000. p. 79.
  27. Choti MA. Hepatic radiofrequency ablation. Cancer J. 2000;6(4):291–292
  28. Shiina S, Teratani T, Obi S, et al. Percutaneous ethanol injection therapy for liver tumors. Eur J Ultrasound. 2001;13(2):95–106
  29. Kady NE, Hasan E, Esmat G, et al. Study of the enhancing effect of sodium chloride injection on radiofrequency ablation of hepatocellular carcinoma. Arab J Gastroenterol. 2009;10(2):63–67
  30. Goldberg SN, Kruskal JB, Oliver BS, et al. Percutaneous tumor ablation: increased coagulation by combining radio-frequency ablation and ethanol instillation in a rat breast tumor model. Radiology. 2000;217(3):827–831
  31. Azab MM, El Hakeem MS, El Sharkawy MK, et al. Evaluation of some non-surgical techniques in management of HCC. AMJ. 2008;5:185–202
  32. Sakr AA, Saleh AA, Moeaty AA, et al. The combined effect of radiofrequency and ethanol ablation in the management of large hepatocellular carcinoma. Eur J Radiol. 2005;54(3):418–425
  33. El Shahawy SH. Management of primary hepatocellular carcinoma by radiofrequency only versus radiofrequency preceeded by percutaneous ethanol injection [MD Thesis]. Tropical Medicine, Faculty of Medicine, Cairo University, 2005.
  34. Rapaccini GL, Pompili M, Caturelli E, et al. Hepatocellular carcinomas <2 cm in diameter complicating cirrhosis: ultrasound and clinical features in 153 consecutive patients. Liver Int. 2004;24(2):124–130
  35. Ahmad R, Abou Median A, Salama H. Assessment of gene therapy in Egyptian patients with hepatocellular carcinoma [MD Thesis]. Tropical Medicine, Faculty of Medicine, Cairo University, 2001.
  36. Lencioni R, Cioni D, Bartolozzi C. Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings and clinical results. Abdom Imag. 2001;26(4):345–360
  37. Mortele KJ, Ros PR. Benign liver neoplasms. Clin Liver Dis. 2002;6(1):119–145
  38. Lam VWT, Ng KK, Chok KSH, et al. Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: analysis of risk factors and prognostic factors. Ann Surg Oncol. 2008;15(3):782–790
  39. Shibata T, Iimuro Y, Yamamoto Y, et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology. 2002;223(2):331–337
  40. Allgaier HP, Deibert P, Zuber I, et al. Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma. Lancet. 1999;353(9165):1676–1677
  41. Okada S. Local ablation therapy for hepatocellular carcinoma. Semin Liver Dis. 1999;19(3):323–328
  42. Mahmoud M. Comparative study between percutaneous ethanol injection and radiofrequency thermal ablation in treatment of hepatocellular carcinoma [MD Thesis]. Tropical Medicine, Faculty of Medicine, Cairo University, 2003.
  43. Livraghi T, Goldberg SN, Meloni F. Percutaneous ablation of small hepatocellular carcinoma (HCC): a prospective comparison between percutaneous ethanol instillation (PEI) and radiofrequency (RF) ablation therapy. Radiology. 1998;209:175
  44. Shiina S, Tagawa K, Niwa Y, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR Am J Roentgenol. 1993;160(5):1023–1028
  45. Vilana R, Bruix J, Bru C, et al. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology. 1992;16(2):353–357
  46. Bruix J, Llovet JM. Locoregional treatments for hepatocellular carcinoma. Baillieres Best Pract Res Clin Gastroenterol. 1999;13(4):611–622
  47. Vallone P, Catalano O, Izzo F, et al. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm. Cardiovasc Intervent Radiol. 2006;29(4):544–551
  48. Lencioni R, Cioni D, Goletti O, et al. Radiofrequency thermal ablation of liver tumors: state-of-the-art. Cancer J. 2000;6:S304–S315
  49. Horiike N, Iuchi H, Ninomiya T, et al. Influencing factors for recurrence of hepatocellular carcinoma treated with radiofrequency ablation. Oncol Rep. 2002;9(5):1059–1062
  50. Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology. 2005;234(3):961–967
  51. Camma C, Di Marco V, Orlando A, et al. Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study. J Hepatol. 2005;42(4):535–540
  52. Rossi S, Di Stasi M, Buscarini E. Percutaneous RF interstitial thermal ablation in the treatment of liver cancer. Am J Roentgenol. 1996;167:759–768
  53. Lin SM, Lin DY, Lin CJ. Percutaneous ethanol injection therapy in 47 cirrhotic patients with hepatocellular carcinoma 5 cm or less: a long-term result. Int J Clin Pract. 1999;53(4):257–262
  54. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques and diagnostic imaging guidance. AJR Am J Roentgenol. 2000;174(2):323–331
  55. Salama HM, Hassan NHA, Hassan EM. Percutaneous radiofrequency ablation of hepatocellular carcinoma using a multiple array needle electrode. HPB. 2003;5:11–18
  56. Tawfik M, Hassan R, Abdel Aziz H, et al. Percutaneous ablation (radiofrequency and ethanol) versus hepatic resection in treatment of HCC in egypt. Afro-Arab Liver J. 2007;6:11–17

PII: S1687-1979(11)00078-5

doi: 10.1016/j.ajg.2011.07.005

Arab Journal of Gastroenterology
Volume 12, Issue 3 , Pages 113-118 , September 2011

Article Tools

* Image Usage & Resolution